Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States
General Info
Coverage type
Country
Time period covered
January, 1998 - December, 2000
Data type
Scientific literature
Citation
Journal
Clin Ther
Pages
1806-25
Publication year
2003
Suggested citation
Migliaccio-Walle K, Getsios D, Caro JJ, Ishak KJ, O'Brien JA, Papadopoulos G, AHEAD Study Group. Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States. Clin Ther. 2003; 25(6): 1806-25.